Healthcare ❯ Pharmaceuticals ❯ Drug Pricing ❯ Semaglutide

Wegovy and Ozempic

Novo Nordisk’s Oral Semaglutide Fails to Slow Alzheimer’s in Dual Phase 3 Trials

Full results will be presented at next week’s CTAD meeting after the company canceled a planned one-year extension.